B Cells--Tumors clinical trials at UC Cancer

• Study of Experimental STRO-001 in Patients With Advanced B-Cell Malignancies (Cancer)

  open to eligible people ages 18 years and up

  First-in-human Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-001 given intravenously every 3 weeks.

  at UC Davis UCSF

Last updated: October 14, 2020